Liang Ma
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 60
- Liver Disease and Transplantation 8
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 13
- Epidemiology top 2%
- Liver Disease Diagnosis and Treatment 35
- Hepatitis B Virus Studies 18
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 10
-
- Cancer Mechanisms and Therapy 15
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 23
- Co-authors
- Jian‐Hong ZhongBang‐De XiangLe‐Qun LiWen‐Feng GongKe YangXue‐Mei YouFeixiang WuJiazhou Ye
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Liang Ma
99 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 100
- Hepatology 1.6k
- Cancer Research 545
- Epidemiology 1.1k
- Oncology 596
- Pathology and Forensic Medicine 260
Countries citing papers authored by Liang Ma
This map shows the geographic impact of Liang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Ma more than expected).
Fields of papers citing papers by Liang Ma
This network shows the impact of papers produced by Liang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Ma. The network helps show where Liang Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 10 | |
| 6 | 2021 | 36 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 42 | |
| 9 | 2020 | 9 | |
| 10 | 2019 | 0 | |
| 11 | 2019 | 13 | |
| 12 | 2018 | 226 | |
| 13 | 2017 | 11 | |
| 14 | 2017 | 13 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 39 | |
| 17 | 2015 | 13 | |
| 18 | 2013 | 2 | |
| 19 | 2013 | 1 | |
| 20 | 2012 | 15 |
About Liang Ma
Liang Ma is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 104 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (60 papers), Liver Disease Diagnosis and Treatment (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers), Hepatitis B Virus Studies (18 papers), Cancer Mechanisms and Therapy (15 papers), Cancer, Lipids, and Metabolism (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Liver Disease and Transplantation (8 papers). The work is most often cited by research in Hepatology (1.6k citations), Cancer Research (545 citations) and Epidemiology (1.1k citations). Liang Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jian‐Hong Zhong, Bang‐De Xiang, Le‐Qun Li, Wen‐Feng Gong, Ke Yang, Xue‐Mei You, Le‐Qun Li, Feixiang Wu, Jiazhou Ye and Xinping Ye. Their work appears in journals such as PLoS ONE, Medicine, Journal of Surgical Oncology, Bioscience Reports and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.